Centrus Energy's stock has plummeted 69% from its October 2025 high of $464.25 to $143, despite holding a robust $4.5 billion backlog. While the company benefits from growing nuclear demand and is the only U.S. public producer of HALEU fuel, near-term challenges persist: revenue is expected to decline through 2028, most backlog orders won't convert to revenue until the late 2020s, and capital-intensive expansion plans will pressure earnings. At 50x forward earnings, the stock appears expensive and lacks near-term catalysts.
Axe note: Centrus Energy’s steep fall and costly valuation make it a tough buy despite a $4.5B backlog.